Company: CVCO
Filing Date: 2025-10-31
Form Type: 10-Q
Source: 0001628280-25-047849
Chunk: 21

Company: CAVCO INDUSTRIES, INC.
Filing Date: 2025-10-31
Form: 10-Q
Item: Part I, Item 1
Chunk 21
---
,029)FINANCING ACTIVITIESPayments for taxes on stock option exercises and releases of equity awards(4,932)(2,921)Proceeds from exercise of stock options1,884 1,793 Payments on finance leases and other secured financings(102)(177)Payments for common stock repurchases(86,086)(72,276)Net cash used in financing activities(89,236)(73,581)Net (decrease) increase in cash, cash equivalents and restricted cash24,609 17,464 Cash, cash equivalents and restricted cash at beginning of the fiscal year375,345 368,753 Cash, cash equivalents and restricted cash at end of the period$399,954 $386,217 Supplemental disclosures of cash flow informationCash paid for income taxes$15,192 $18,825 Cash paid for interest$137 $30 Supplemental disclosures of noncash activityChange in GNMA loans eligible for repurchase$(212)$496 

See accompanying Notes to Consolidated Financial Statements

3

CAVCO INDUSTRIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. Basis of Presentation

The accompanying unaudited Consolidated Financial Statements of Cavco Industries, Inc. and its subsidiaries (collectively, "we," "us," "our," the "Company" or "Cavco") have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for Quarterly Reports on Form 10-Q and Article 10 of SEC Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("GAAP") have been condensed or omitted pursuant to such rules and regulations. In addition, references throughout to numbered "Notes" refer to these Notes to Consolidated Financial Statements (Unaudited), unless otherwise stated.In the opinion of management, these financial statements include all adjustments, including normal recurring adjustments, which are necessary to fairly state the interim results for the periods presented. We have evaluated subsequent events after the balance sheet date through the date of the filing of this report with the SEC, and there were no disclosable subsequent events other than those mentioned in Note 19. These Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the Notes to the Consolidated Financial Statements included in our 2025 Annual Report on Form 10-K for